网站地图 - XML地图 - 设为首页 - 加入收藏
您的当前位置:主页 > 国内 > 正文

偷天换日

Chinese researchers identify target to develop depression drug using traditional ethnic medicine in Yunnan_我的网站

小清新

A |     近日,汪峰21岁大女儿汪曼熙(小苹果)近照刷屏,178cm超模身材与神似生母葛荟婕的清冷气质引发热议。汪曼熙身高已确认达到178cm,超越父亲汪峰(176cm),被网友称为“九头身大长腿”。

B |     

Qingyangshen, or Root of Auricledleaf Swallowwort, a traditional ethnic medicinal plant long used in Southwest China's Yunnan Province. Photo: Scrrenshot from website
    Qingyangshen, or Root of Auricledleaf Swallowwort, a traditional ethnic medicinal plant long used in Southwest China's Yunnan Province. Photo: Scrrenshot from website
A Chinese research team has identified a new potential target to develop antidepressant drug from Qingyangshen, or Root of Auricledleaf Swallowwort, a traditional ethnic medicinal plant long used in Southwest China's Yunnan Province, according to Kunming University of Science and Technology, Science and Technology Daily reported Sunday.
The team, led by professors Xu Tianrui and Xiang Cheng from the university's School of Life Science and Technology, found that Qingyangshen glycosides, the plant's core active compound, can alleviate depression-related behaviors by simultaneously suppressing inflammation, reducing oxidative damage and stabilizing neurotransmitters in the brain.
The findings were published in the international journal Phytomedicine.  
Depression has become a widespread mental health disorder globally, while existing clinical drugs fail to provide effective treatment for more than 30 percent of patients, according to the researchers. Previous studies have established a strong link between chronic inflammation and depression, but existing anti-inflammatory drugs have limited targeting capabilities, underscoring the need for new therapeutic targets and lead compounds.
Qingyangshen, a plant of the Cynanchum genus in the Apocynaceae family, has long been used as a traditional medicine by ethnic groups including the Naxi, Yi and Bai peoples in Yunnan, mainly for treating neurological conditions such as epilepsy and neurasthenia. 
The researchers systematically examined the pharmacological effects of Qingyangshen extract and its core active compound, Qingyangshen glycosides. Tests using mouse, zebrafish and fruit fly models repeatedly showed that the compound significantly improved depression-related behaviors induced by inflammation, according to the report.
To identify the compound's target, the team developed a dual-discrimination model for four subtypes of prostaglandin E2 receptors and combined it with AI-powered machine learning. The researchers screened hundreds of G protein-coupled receptors and identified the prostaglandin E2 subtype 4 receptor as the direct target of Qingyangshen glycosides.
Multiple molecular experiments confirmed that the compound binds directly to the receptor and acts as an inhibitory ligand. Further experiments involving animals with the receptor knocked out in the hippocampus showed that the antidepressant effects of Qingyangshen glycosides disappeared completely when the receptor was absent, providing the first in-vivo evidence that the receptor is essential for the compound's therapeutic effects.
An illustration of the research. Photo: Screenshot from the website
    An illustration of the research. Photo: Screenshot from the website
The study establishes the prostaglandin E2 subtype 4 receptor as a potential new target for antidepressant drug development and points to a new approach to treating depression through inflammatory pathways. It also identifies Qingyangshen glycosides as a potential lead compound for developing highly targeted anti-inflammatory antidepressants, creating a research chain from ethnic medicinal plants and active compounds to drug targets and new drug development.
Global Times
。身材高挑纤瘦但“瘦而不柴”,整体呈现舒展挺拔的体态,侧脸与身形轮廓线条流畅。常以黑色露腰上衣搭配高腰长裙或短裤出镜,凸显纤细腰线与优越比例。

C | 生母葛荟婕曾是中国顶级女模,小苹果五官复刻母亲冷艳风格,继承高挑身材与超模气质。

D | 被形容为“完全翻版葛荟婕”,颜值在一众星二代里算是佼佼者,不少网友喊话“出道吧”。

E |

Current article:http://www.hanninhuaxituochunkui.pics/news/20260826_3325927.html

Published on:16:55:18


注:凡本网注明来源非本站的作品,均转载自其它媒体,并不代表本网赞同其观点和对其真实性负责。
本站致力于帮助文章传播,希望能够建立合作关系。
若有任何不适的联系以下方式我们将会在24小时内删除。联系方式:
Copyright © 2018 我的网站 版权所有